Journal of Thoracic Oncology Oncology

Final Analysis From PECATI Phase 2 Trial: Lenvatinib in Combination With Pembrolizumab in Pretreated Advanced B3 Thymoma and Thymic Carcinoma

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →